Searle Company Ltd · PSX:SEARL
Searle — The Searle Company — Investor Presentation (2023)
15 slides from Searle's investor presentation, 2023
Slide 1: The Searle Company Limited
The Searle Company Limited
Slide 2: Subsidiaries of Searle
Subsidiaries of Searle • Searle is 58.37% owned by IBL Group. The Searle • Originally founded in US in 1888 by Gideon D. Searle. Company Limited • Incorporated in Pakistan as a Private Limited Company in 1965 as a subsidiary of G.D. Searle & Co., USA. 74.1% 90.6% 100% 100% 100% 100% 100% 100% IBL Se
Slide 3: Our Footprints
Our Footprints E X C E L L E N C E I N C O M M E R C I A L O P E R AT I O N S ND 1 No. 2 1Billion Plus Billion Rupee Club i. ii. iii. iv. Cardiovascular Pain Management Gynae Cough Suppressant - Largest Pharmaceutical Company In terms of Product Consumptions(Unit) 6 Brands - Exporter in Pakistan v.
Slide 4: Achievements
Achievements COMMIT ME N T TO E XCE LLE NCE Searle was ranked as the most outstanding company in Healthcare sector of Pakistan as per Asiamoney’s Outstanding Companies Poll, 2018, 2021 & 2023. Searle has been part of Forbes Asia’s Best Under A Billion rankings from 2017 to 2019. Searle won Asia’s Be
Slide 5: Pharmaceutical Industry
Pharmaceutical Industry The pharmaceutical sector recorded revenue of PKR 786bn (USD 2.8 bn) in last 12 months with YoY growth of 16.5% (against PKR 675bn in last year). Market share of Multinational & Market share of Top 100 National companies 2.80% 28.00% No. of Companies Multinational 26 Top 100
Slide 6: Our Product Portfolio
Our Product Portfolio M A R K E T I N G A U T H O R I Z AT I O N 20 651 Biotech Local Registration Registration 398 70 Global Enlistments Registration 52 7 Medical Drug Device Manufacturing Registration License
Slide 7: Our Brands
Our Brands LEADING BRANDS IN THEIR THERAPEUTIC AREA Cough • Hydryllin Muscle Relaxant • Nuberol ORS • Peditral Cardiovascular • Extor, Spiromide, Byscard Analgesic • Tramal, Rotec Gastrointestinal • Gravinate, Lomotil, Selanz Antibiotics • Negram Anaemia • Venofer Eye care • Cosopt, Trusopt
Slide 8: Our Partners
Our Partners T R U S T O F O U R A F F I L I AT O R S
Slide 9: Our Presence
Our Presence Export contributes 10% to our revenue Tajikistan Iraq Azerbaijan Kosovo Uzbekistan Afghanistan Oman Myanmar Sudan Laos Senegal Nigeria Yemen Vietnam Ethiopia Cambodia Ivory Coast Uganda Sri Lanka Kenya Philippines Ghana Cameroon Rwanda Mali Tanzania Maldives Kenya Burundi Mauritius Exis
Slide 10: Our Revenue
Our Revenue 33.9 bn We have grown our revenue from 1.3 bn to 33.9 bn with a CAGR of 15.6% 1.3 bn 2000 2023 CAGR – 15.6% ‘Mn 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 Revenue 1,342 1,507 1,566 1,733 2,065 2,337 2,818 2,694
Slide 11: Corporate Social Responsibility
Corporate Social Responsibility Our humble CSR effort s • Considering the importance of education and believing it to be a right of every citizen, Searle supports The Citizens Foundation to help them achieve the cause, empowering children to become agents of positive change. • Continuing with our ph
Slide 12: Our Collaboration
Our Collaboration IBA Karachi- established the Rashid Abdulla Consumer Neuroscience Lab NED University - established a research facility, Rashid Abdullah Research Centre LUMS - Contributed to setup of MDR Laboratory Karachi University - Research & Development Centre at ICCBS
Slide 13: Financial Information
Financial Information 2023* 2022 2021 Revenue 21,641,282 17,737,282 16,569,596 GOLY% 22.01% 7.05% SG&A % 31.00% 34.45% 31.93% Operating profit % 17.36% 23.98% 24.48% Standalone PAT % 1.40% 11.79% 12.81% EPS 0.77 5.36 7.01 Cash Dividend - - 20.00% Stock Dividend - 25.00% 30.00% 2023* 2022 2021 Revenu
Slide 14: This year…
This year… • The Searle Company Limited became first Pakistani Pharmaceutical company to get the GMP approval for its manufacturing facility from the Ministry of Health, Sultanate of Oman. • The Searle Company Limited has entered into license agreement with Mabwell Pharmaceuticals, China under which
Slide 15: Thank you
Thank you